Pipecuronium

It is mainly used for muscle relaxation during general anesthesia, and is mostly used for anesthesia in long surgeries (more than 20 to 30 minutes).

Like other neuromuscular blockers, the dose of pipecuronium should be individualized. The dose should be determined based on the method of anesthesia, the duration of surgical operation, the interaction with other medications before and during anesthesia, concomitant diseases and the patient's physical condition. To monitor neuromuscular blockade and recovery. It is recommended to use a peripheral nerve stimulator. The first dose of pipecuronium should be injected intravenously, followed by divided injections of maintenance doses to maintain muscle relaxation, or continuous infusion to achieve the required muscle relaxation time. Like other neuroblockers, pipecuronium should be used under the conditions of a physician and specific corresponding artificial respiration equipment. The following doses are general principles for the first and maintenance doses of pipecuronium. Under stable anesthesia conditions, whether or not pipecuronium is used for endotracheal intubation, appropriate muscle relaxation can be guaranteed during medium and long-term surgery. For adult patients who need moderate or long-term surgery, intravenous administration can be used. If it is necessary to achieve muscle relaxation for induction of intubation, the general dose is 0.06-0.08 mg/kg body weight; when used in combination with succinylcholine, the dosage of pipecuronium bromide is 0.04-0.06 mg/kg body weight. For patients with renal insufficiency, the dosage of pipecuronium bromide generally does not exceed 0.04 mg/kg body weight. When repeated administration, the repeated dose is 1/4-1/3 of the initial dose. The increase in dose prolongs the muscle relaxation time. Or follow the doctor's advice.

Sichuan Tiandao Pharmaceutical Co., Ltd.

• Founded in:

  2007-07-20

• Address:

  Industrial Park, Fuji Town, Lu County, Luzhou City, Sichuan Province

• Tax NO.:

  91510500660250013R

• Registered Funds:

  28.55 million yuan

• Email:

  Log in to view